Načítá se...
Naltrexone HCI/bupropion HCI for chronic weight management in obese adults: patient selection and perspectives
Naltrexone, an opiate antagonist, and bupropion, a noradrenergic/dopaminergic antidepressant, have many effects on the reward systems of the brain. These medications impact eating behavior, presumably via their impact on food reward. However, only bupropion induces weight loss in obese individuals,...
Uloženo v:
| Vydáno v: | Patient Prefer Adherence |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4862388/ https://ncbi.nlm.nih.gov/pubmed/27217728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S84778 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|